<DOC>
	<DOCNO>NCT02735083</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety efficacy UCART 19 administration patient advance lymphoid malignancy .</brief_summary>
	<brief_title>A Study Evaluate Long-term Safety Patients With Advanced Lymphoid Malignancies Who Have Been Previously Administered With UCART19</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Written inform consent obtain prior studyspecific procedure ( patient parent ( ) legal representative ) enrolment parent study compassionate use program ; Patient dose UCART19 complete discontinue early sponsor investigatorinitiated study test UCART19 , patient administer UCART19 special access scheme ( compassionate use ) ; Female patient childbearing potential male patient partner childbearing potential must continue use effective method birth control well partner . No exclusion criterion study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>